Skip to main content
. Author manuscript; available in PMC: 2023 Jun 1.
Published in final edited form as: Ageing Res Rev. 2023 Mar 31;87:101923. doi: 10.1016/j.arr.2023.101923

Fig. 6.

Fig. 6.

IPD subgroup analyses of vitamin D3 supplementation and cancer-specific survival in the cancer population by age, sex, BMI, ethnicity, vitamin D baseline level, adherence, cancer stage, cancer site, time of cancer diagnosis in all trials (panel A, main analysis) and restricted to trials with a daily dosing regimen (panel B, post-hoc analysis).